8:00 - 9:00 am

Grunberg Memorial Keynote: Delivering High-Quality   Equitable   Cancer Care: Aligning Action for Impact

 Chief Diversity and Inclusion Officer

 American Society of Clinical Oncology

 Poster Session #2

 Treatment with Immune Checkpoint Inhibitors -What  We Know and What We Don't Know 
 Focusing on Management of Immune Related Adverse Events     (irAEs)

 Keisuke Shirai, MD, MSc

 Professor of Medicine

 Geisel School of Medicine, Dartmouth

       Matthew Marston                 Adam Youngblood

Pharm.D., MBA, BCPS, BCOP         PharmD, BCPS

        Shannon Hickey Hannon            Nikki Langstaff

              BSN, RN                                PT, MS, CLT

11:10 am - 12:00 pm

PODIUM PRESENTATIONS

• VTE Risk Assessment and Prevention in Cancer Patients in the Community Oncology Setting - Yoni Resnick, PharmD, New England Cancer Specialists

• Trends and Outcomes of Salvage Lobectomy for Early-Stage Non-Small Cell Lung Cancer - Sam Afshari, UVM Larner College of Medicine

• Modified frailty index (mFI) in elderly patients with glioblastoma correlates with survival - Amy Chang, University of Vermont Larner College of Medicine

FACILITATOR

Nicole Messier, BSN, RN, OCN, ONN_CG

Katherine Lafferty, MS, CGC Nikki Langstaff, PT, MS, CLT

   Marla Tryder, RD, LD Amy Bertrand, BSW, MPS